KalVista Pharmaceuticals (KALV) Operating Income (QoQ) (2014 - 2025)
KalVista Pharmaceuticals (KALV) Operating Income (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -7.23% |
| Oct 31, 2024 | -3.61% |
| Jul 31, 2024 | 8.75% |
| Apr 30, 2024 | -46.16% |
| Jan 31, 2024 | -11.45% |
| Oct 31, 2023 | -2.24% |
| Jul 31, 2023 | 8.30% |
| Apr 30, 2023 | -17.75% |
| Jan 31, 2023 | -4.10% |
| Oct 31, 2022 | 1.65% |
| Jul 31, 2022 | 1.85% |
| Apr 30, 2022 | -0.48% |
| Jan 31, 2022 | -13.05% |
| Oct 31, 2021 | -20.94% |
| Jul 31, 2021 | -8.17% |
| Apr 30, 2021 | -42.55% |
| Jan 31, 2021 | 0.97% |
| Oct 31, 2020 | 11.51% |
| Jul 31, 2020 | -61.25% |
| Apr 30, 2020 | 29.61% |